对血清CA 19-9作为胰腺恶性瘤诊断标记物的评估
S M F Ahmed1, A K M Ullah, S Mohammed
1Dr SM Ferdous Ahmed, Assistant Professor, Department of Casualty, Sir Salimullah Medical College Mitford Hospital, Dhaka, Bangladesh;
Mymensingh medical journal : MMJ
|April 1, 2024
概括
血清CA 19-9瘤标志物显示胰腺癌诊断的中度准确性. 38U/ml的切断值提供了77.8%的灵敏度和特异性,而更高的门增加了特异性,但降低了灵敏度.
科学领域:
- 在瘤学瘤学.
- 临床化学 临床化学
背景情况:
- 血清CA 19-9是用于胆道胰腺恶性瘤的广泛使用的瘤标志物.
- CA 19-9水平升高可以发生在良性疾病或其他癌症中,在胰腺癌中可能是正常的.
- 确定最佳的切线值对于准确的诊断解释至关重要.
研究的目的:
- 评估血清CA 19-9在诊断胰腺恶性瘤中的敏感性和特异性.
- 在胰腺癌检测的背景下,确定CA 19-9的有效切断值.
主要方法:
- 在2016年6月至2017年5月期间进行了一项比较研究.
- 使用接收器操作特征 (ROC) 曲线分析来确定最佳切断值.
- 灵敏度,特异性,正预测值 (PPV) 和负预测值 (NPV) 在不同的值下计算.
主要成果:
- 在38U/ml的截止值 (通过ROC曲线确定),CA 19-9显示了77.8%的灵敏度,特异性,PPV和NPV.
- 将CA 19-9的值提高到100U/ml和120U/ml,导致更高的特异性 (88.9%和94.4%) 和PPV (86.7%和92.3%).
- 然而,这些较高的门导致灵敏度 (72.2%和66.7%) 和净净值 (76.2%和73.9%) 的下降.
结论:
- CA 19-9瘤标志物对胰腺癌具有中等的诊断效用.
- 38U/ml的切割值在灵敏度和特异性方面提供了平衡的性能.
- 更高的切线值可能会提高特异性,但会损害灵敏度,在临床应用中需要仔细考虑.
相关概念视频
01:29Chronic Pancreatitis II: Collaborative Care
86
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
86
01:30Acute Pancreatitis II: Clinical Manifestations and Management
122
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
122